An analysis of PARTNER 2 data, published in the June edition of the Journal of the American College of Cardiology, suggests transcatheter aortic valve replacement (TAVR) within failed bioprosthetic surgical aortic valves is a viable long-term solution for high-risk individuals, with patients seeing “excellent” functional and quality of life outcomes three years after the procedure.

A Wisconsin high schooler is speaking up for stroke awareness after she suffered a stroke of her own during gym class, WAOW reported—an event her doctors said was brought on by her birth control pills.

Red and white meat have equally harmful effects on blood cholesterol levels, according to research published in the American Journal of Clinical Nutrition, contradicting the popular idea that lighter proteins like chicken are more heart-healthy than their counterparts like beef and lamb.

CVD and depression are a two-way street, capable of inflicting considerable damage on one another. So how do heart patients protect their mental health after a life-threatening event like MI?

The American Society for Radiation Oncology (ASTRO) is championing bipartisan legislation introduced Wednesday, June 5, that would reduce prior authorization practices found to delay patient access to necessary cancer treatments.

Active-duty Army personnel in the U.S. have poorer cardiovascular health than the larger civilian population, researchers have found—especially when it comes to blood pressure.

Patients with end-stage renal disease (ESRD) face higher risks of in-hospital mortality and bleeding with transcatheter aortic valve replacement (TAVR) than patients who aren’t dialysis-dependent, researchers report in the Journal of the American College of Cardiology.

Arizona-based R3 Stem Cell, LLC is under fire this week after the FDA sent the company an untitled, three-page letter detailing significant shortcomings in their process.